DelveInsight has launched a new report on "Pancreatic Cancer-Market Insights, Epidemiology, and Market Forecast-2030”.
DelveInsight’s “Pancreatic Cancer–Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of Pancreatic Cancer, historical and forecasted epidemiology as well as the Pancreatic Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Report:
-
According to a study in 2018, 458,918 new cases of pancreatic cancer were registered worldwide, representing 2.5% of all cancers. The age-standardized rate (ASR) incidence was highest in Europe (7.7 per 100,000 people) and North America (7.6 per 100,000 people). A slight difference in pancreatic cancer incidence among genders was observed. It was more common in men (5.5 per 100,000, 243,033 cases) than in women (4.0 per 100,000, 215,885 cases). The incidence rate for both sexes increases with age. Pancreatic cancer was seldom diagnosed before 55 years of age, and it can be defined as a disease of elderly populations because the highest incidence is reported in people over 70 years.
-
According to the observation, there were 53,265 patients diagnosed with pancreatic cancer in England between 1998 and 2006. Around 411 patients were aged between 20 and 39, which equated to an average of 23 cases per year. There were less than 50 cases per year for those in their 30s and an average of 185 per year for those in their 40s. The age-specific incidence of pancreatic cancer increased with age and was highest in males and females aged over 80. The incidence remained stable in all age groups over 50, except for females aged 50-59 where there was a slight increase in incidence (p =0.039).
Key benefits of the report:
1.The Pancreatic Cancer market report covers a descriptive overview and comprehensive insight of the Pancreatic Cancer epidemiology and Pancreatic Cancer market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2.The Pancreatic Cancer market report provides insights into the current and emerging therapies.
3.Pancreatic Cancer market report provides a global historical and forecasted market covering drug outreach in 7MM.
4.The Pancreatic Cancer market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Pancreatic Cancer market.
Request for sample pages: https://www.delveinsight.com/sample-request/pancreatic-cancer-market
Pancreatic Cancer: Overview
Pancreatic adenocarcinoma is one of the most aggressive forms of cancer and is projected to arise as the second leading cause of cancer-related deaths in Europe and the United States shortly. In the US, pancreatic cancer is the 9th or 10th most commonly diagnosed cancer (depending on gender).
A clinical/radiographic stage classification for pancreatic cancer suggests a three-stage classification (potentially resectable, locally advanced, and advanced) of pancreatic cancer involvement based on radiological findings.
The key players involved in the Pancreatic Cancer market:
-
FibroGen
-
SynCore Biotechnology
-
Galera Therapeutics
-
Singh Biotechnology
-
AB Science
-
AstraZeneca
-
NanOlogy
-
NantKwest/ImmunityBio
-
Rafael Pharmaceuticals
The launch of the emerging therapies is expected to significantly impact the Pancreatic Cancer treatment scenario in the upcoming years:-
Drug covered
-
Pamrevlumab (Anti CTGF antibody)
-
EndoTAG-1 (ET)
-
GC4419
-
SBT-100
-
Masitinib
-
AZD6738
-
NanoPac
-
PD-L1 t-hank and N-803
-
CPI-613 (devimistat)
Request a free sample report @https://www.delveinsight.com/sample-request/pancreatic-cancer-market
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Pancreatic Cancer Patient Share (%) Overview at a Glance
5. Pancreatic Cancer Market Overview at a Glance
6. Pancreatic Cancer Disease Background and Overview
7. Pancreatic Cancer Epidemiology and Patient Population
8. Country-Specific Patient Population of Pancreatic Cancer
9. Pancreatic Cancer Current Treatment and Medical Practices
10. Unmet Needs
11. Pancreatic Cancer Emerging Therapies
12. Pancreatic Cancer Market Outlook
13. Country-Wise Pancreatic Cancer Market Analysis (2017–2030)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Pancreatic Cancer Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Pancreatic Cancer-Pipeline Insights, 2021
"Pancreatic Cancer-Pipeline Insight, 2021" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Pancreatic Cancer market. A detailed picture of the Pancreatic Cancer pipeline landscape is provided, which includes the disease overview and Pancreatic Cancer treatment guidelines.
Pancreatic Cancer-Epidemiology Forecast to 2030
DelveInsight's 'Pancreatic Cancer-Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Pancreatic Cancer{;l epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
